Close

Analyst Ratings for 4D Pharma PLC (LBPS)

LBPS Rating Summary

  |   Expand Research on LBPS
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 5 / 10
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
6/27/2022 Chardan Capital Markets Globa Amusa Downgrade Neutral
(Buy)
N/A
(N/A)
1.65
(1.65)
0% Details
5/13/2021 Ladenburg Thalmann Michael Higgins New Coverage Buy
(N/A)
35.00
(N/A)
10.55
(1.65)
-84.36% Details